Close Menu

Not Wanted

A Stanford University study suggests that, like organ transplants, human embryonic stem cells may come with a high probability of rejection. Joseph Wu and his colleagues injected hESCs into mice with compromised immune systems and into normal mice. The mice with compromised immune systems did well while the others died within 10 days. "[This result is] not a disappointment, it's more of a reality check," Wu says at sciam.com.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.